Experts in immune-oncology therapies developing proprietary FHAB™ (Fully Human Albumin Binding) technology. (NASDAQ: $SONN)

ID: 912326773047742464

linkhttps://www.sonnetbio.com/news-media/press-releases calendar_today25-09-2017 14:43:47